The Science · Article

What researchers are studying in Nigella sativa: the honest picture

By M Miah & Raheem Miah, Co-Founders — Nutrition Chemist · Formulated with British PhD scientists

Black seed oil carries no authorised health claims in the UK. That doesn’t mean research doesn’t exist — it means you deserve to know what that research actually says, and what it doesn’t. Here is the honest summary.

πŸ”¬

What the evidence map looks like

Extensive laboratory research, a meaningful number of animal studies, a growing body of human trials — none of which have been evaluated by UK regulators for a health claim. We describe what researchers have studied; we do not make claims the evidence and the law do not support.

Context

Reading the research: what to trust and why

References

  1. Hannan MA, Rahman MA, Sohag AAM, et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients. 2021;13(6):1784. PubMed 34073784. — Comprehensive review of Nigella sativa phytochemistry, pharmacological research and safety profile; summarises the breadth of laboratory and clinical research on thymoquinone and related compounds.
  2. Salem A, Bamosa A. Effect of Nigella sativa on general health and immune system in young healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. F1000Res. 2023;10:1199. PubMed 37901256. — Randomised, double-blind, placebo-controlled trial in 52 healthy young volunteers (48 male, 4 female) examining the effect of Nigella sativa on immunity-related parameters and general health markers over 3 months.
  3. Gholamnezhad Z, Havakhah S, Boskabady MH. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. J Ethnopharmacol. 2016;190:372–86. PubMed 27364039. — Review of preclinical and clinical literature on Nigella sativa and thymoquinone, covering the range of outcomes studied and the gap between laboratory evidence and human trial evidence.
Black Seed Oil Science Series
Shop Black Seed Oil High Strength β†’
← Back to the science hub

References

  1. Khaikin E, Chrubasik-Hausmann S, Kaya S, Zimmermann BF. Thymoquinone content of Nigella sativa products. Nutrients. 2022;14(17):3666. PubMed 36079759. β€” HPLC analysis of 11 commercial black seed oils; TQ content ranged from 3 to 809 mg/100 g (∼260-fold variation), concluding products should be regulated for TQ content.
  2. Alkhatib H, Mawazi SM, Al-Mahmood SMA, Zaiter A, Doolaanea AA. Thymoquinone content and quality of Nigella sativa L. oils. J Pharm Bioallied Sci. 2020;12(3):232–8. PubMed 33100788. β€” HPLC analysis of 10 commercial products found TQ ranging from 0.07% to 1.88% wt/wt (27-fold variation), attributable to source and extraction method; authors recommended standardisation.
  3. Khader M, Eckl PM. Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci. 2014;17(12):950–7. PubMed 25859298. β€” Established TQ as the most prominent constituent of N. sativa essential oil, noting 406 PubMed-indexed research reports published on TQ since 1960 at time of writing.
  4. Islam MT, Sarkar C, El-Kersh DM, et al. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytotherapy Research. 2021;35(9):4849–77. PubMed 34073784. β€” Comprehensive review establishing TQ as the primary phytochemical responsible for black cumin’s pharmacological characteristics, with the most prominent research focus.

Note: This article describes composition and analytical data only. Black seed oil holds no authorised health claims under UK food supplement regulations (GB NHC Register).